期刊文献+

自体肿瘤疫苗主动特异性免疫治疗对结肠癌患者细胞免疫功能的影响 被引量:2

下载PDF
导出
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2002年第10期746-748,共3页 Chinese Journal of Clinical Oncology
基金 陕西省卫生厅科学基金(编号:9929) 西安交通大学博士流动基金资助(编号:011004)
  • 相关文献

参考文献9

  • 1Vermorken JB, Claessen AM, van Tinteren H, et al. Active specific immunotherapy for stage Ⅱ and stage Ⅲ human colon cancer: a randomised trial. Lancet, 1999,353(9150):345~350
  • 2Harris JE, Ryan L, Hoover HC Jr, et al. Adjuvant active specific immunotheropy for stage Ⅱ and Ⅲ colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncol ogy Group Study E5283. J Clin Oncol, 2000,18(1):148~157
  • 3Nakamori M, Iwahashi M, Tani M, et al. New therapeutic strategy agaist colon cancer based on a tumor-specific approach. Gan To Kagaku Ryoho, 2000,27(14):2209~2215
  • 4Tarasov VA, Filatov MV, Kisliakova TV, et al. Combined surgical and imnunotherapeutic treatment of patients with fourth stage colon cancer. Hybridoma, 1999,18:99~102
  • 5Chu Y, Hu Hm, Winter H, et al. Examining the immune response in sentinel lymph nodes of mice and men. Eur J Nucl Med, 1999,26(4Suppl) :S50~53
  • 6Kaji D and Hengartner H. Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses. Curr Opin Immunol, 1996,8(4):472~477
  • 7Clark WR, Walsh CM, Glass AA, et al. Cell-mediated cytotoxicity in perforin-less mice. Int Res Immunol, 1995,13(1):1~14
  • 8Liu CC, Persechini F. Perforin and lymphocyte mediated cytolysis. Immunol Rev, 1995,146:145~175
  • 9van Parijs LJ, Abbas AK. Role of Fas-mediated cell death in the regulation of immune responses. Cuur Opin Immunol, 1996,8(3):355~361

同被引文献29

  • 1王永生,田聆,魏于全.结直肠癌疫苗研究进展[J].国外医学(肿瘤学分册),2004,31(7):545-548. 被引量:1
  • 2张银旭,张俊华,刘晓梅,李锦成,董哲.自体肿瘤细胞疫苗在结肠癌术后的主动免疫治疗研究[J].中国医师进修杂志(外科版),2007,30(3):17-19. 被引量:1
  • 3Bjorkdahl O, Dohlsten M, Sjogren HO. Vaccination with B16 melanoma cells expressing a secreted form of interleukin-lbeta induces tumor growth inhibition and an enhanced immunity againstthe wild-type B16 tumor. Cancer Gene Ther, 2000, 7:1365-1374.
  • 4Truffa-Bachi P, Lefkovits I I, Rudolf Frey J. Proteomic analysis of Tcell activation in the presence of cyclosporin A: immunosuppressor and activator removal induces de novo protein synthesis. Mol Immunol,2000, 37:261.
  • 5Yoshida A, Maruyama H, Kumagai T, et al. Enhanced UVfemalel tumor growth in CBF1 mice infected with Schistosoma mansoni due to modulation of Thl-like responses. Parasitol Int, 2002, 51 : 177-186.
  • 6Shimizu J, Yamazaki S, Takahashi T, et al. Stimulation of CD25( + ) CD4 ( + ) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol, 2002, 3:135-142.
  • 7Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4( + )CD25( + ) regulatory T cells.2003, 4:330-336.
  • 8Liyanage UK, Toore TT, Joo HG, et al. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol, 2002,169 : 2756-2761.
  • 9Curiel TJ, Coukos G, Zou L, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med, 2004,10:942-949.
  • 10Stock P, Akbari O, Berry G, et al. Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity. Nat Immunol, 2004, 5 : 1149-1156.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部